Jasiecki_2019_Sci.Rep_9_5223

Reference

Title : Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease - Jasiecki_2019_Sci.Rep_9_5223
Author(s) : Jasiecki J , Limon-Sztencel A , Zuk M , Chmara M , Cysewski D , Limon J , Wasag B
Ref : Sci Rep , 9 :5223 , 2019
Abstract : While the life expectancy of the population has increased, Alzheimer's disease (AD) has emerged as one of the greatest health problems of old age. AD is characterized by neuronal loss and cognitive decline. In the AD brain, there is a decrease in levels of acetylcholinesterase (AChE) and an increase in the levels of the related enzyme butyrylcholinesterase (BChE), that accumulate in plaques and tangles. Apolipoprotein E (ApoE) is a major cholesterol carrier and plays an important role in maintaining lipid homeostasis. APOE-epsilon4 constitutes the most important known genetic risk factor for late-onset AD. It has been proposed that the BCHE-K allele (Ala539Thr) acts in synergy with the APOE-epsilon4 allele to promote risk for AD. However, there is insufficient evidence to support a correlation. Most studies focused only on the coding regions of the genes. In this study, we analyzed sequence regions beyond the BCHE coding sequence. We found synergy between APOE-epsilon4 and SNPs localized in 5'UTR (rs1126680) and in intron 2 (rs55781031) of the BCHE-K allele (rs1803274) in 18% of patients with late-onset AD (n = 55). The results show that the coexistence of the APOE-epsilon4 allele and 3 SNPs in the BCHE gene is associated with a highly elevated risk of late-onset AD. SNP (rs1126680) in 5'UTR of the BCHE gene is located 32 nucleotides upstream of the 28 amino acid signal peptide. Mass spectrometry analysis of the BChE protein produced by SNP (rs1126680) showed that the mutation caused an in frame N-terminal extension of 41 amino acids of the BChE signal peptide. The resultant variant with a 69 amino acid signal peptide, designated N-BChE, may play a role in development of AD.
ESTHER : Jasiecki_2019_Sci.Rep_9_5223
PubMedSearch : Jasiecki_2019_Sci.Rep_9_5223
PubMedID: 30914707

Related information

Citations formats

Jasiecki J, Limon-Sztencel A, Zuk M, Chmara M, Cysewski D, Limon J, Wasag B (2019)
Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease
Sci Rep 9 :5223

Jasiecki J, Limon-Sztencel A, Zuk M, Chmara M, Cysewski D, Limon J, Wasag B (2019)
Sci Rep 9 :5223